Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits.

MLA

Laserna-Mendieta, Emilio J., et al. “Comparison of a New Rapid Method for Determination of Serum Anti-Adalimumab and Anti-Infliximab Antibodies with Two Established ELISA Kits.” Journal of Pharmaceutical and Biomedical Analysis, vol. 198, May 2021, p. 114003. EBSCOhost, https://doi.org/10.1016/j.jpba.2021.114003.

APA

Laserna-Mendieta, E. J., Salvador-Martín, S., Marín-Jiménez, I., Menchén, L. A., López-Cauce, B., López-Fernández, L. A., & Lucendo, A. J. (2021). Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits. Journal of Pharmaceutical and Biomedical Analysis, 198, 114003. https://doi.org/10.1016/j.jpba.2021.114003

Chicago

Laserna-Mendieta, Emilio J, Sara Salvador-Martín, Ignacio Marín-Jiménez, Luis A Menchén, Beatriz López-Cauce, Luis A López-Fernández, and Alfredo J Lucendo. 2021. “Comparison of a New Rapid Method for Determination of Serum Anti-Adalimumab and Anti-Infliximab Antibodies with Two Established ELISA Kits.” Journal of Pharmaceutical and Biomedical Analysis 198 (May): 114003. doi:10.1016/j.jpba.2021.114003.